Literature DB >> 18323804

Preparation of magnetic resonance contrast agents activated by beta-galactosidase.

Lauren M Urbanczyk-Pearson1, Thomas J Meade.   

Abstract

The preparation of beta-EgadMe and alpha-EgadMe, magnetic resonance (MR) contrast agents that can be used for in vivo detection of beta-galactosidase, is described. Diastereomerically pure beta-EgadMe can be synthesized by kinetically resolving the starting material as described in Step 1. The total time for the preparation of the racemic mixture of beta-EgadMe is about 8 d, and the total time for an diastereomerically resolved agent is about 9 d. The final metallated agent is stable at room temperature as a solid or in aqueous buffer (pH 5.5-10) indefinitely. Diastereomerically pure alpha-EgadMe can be prepared by beginning the synthesis with enantiomerically pure bromopropionic acid. The total time for the preparation of racemic alpha-EgadMe or diastereomerically pure alpha-EgadMe is about 8 d. The final metallated agent is stable at room temperature as a solid or in aqueous buffer (pH 5.5-10) indefinitely.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323804     DOI: 10.1038/nprot.2007.529

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  9 in total

Review 1.  Lanthanide probes for bioresponsive imaging.

Authors:  Marie C Heffern; Lauren M Matosziuk; Thomas J Meade
Journal:  Chem Rev       Date:  2013-12-13       Impact factor: 60.622

2.  A cell-permeable gadolinium contrast agent for magnetic resonance imaging of copper in a Menkes disease model.

Authors:  Emily L Que; Elizabeth J New; Christopher J Chang
Journal:  Chem Sci       Date:  2012-04-18       Impact factor: 9.825

3.  Gadolinium-encapsulating iron oxide nanoprobe as activatable NMR/MRI contrast agent.

Authors:  Santimukul Santra; Samuel D Jativa; Charalambos Kaittanis; Guillaume Normand; Jan Grimm; J Manuel Perez
Journal:  ACS Nano       Date:  2012-07-18       Impact factor: 15.881

Review 4.  Molecular imaging of in vivo gene expression.

Authors:  Allison S Harney; Thomas J Meade
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

5.  Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels.

Authors:  Ann-Marie Broome; Gopal Ramamurthy; Kari Lavik; Alexander Liggett; Ian Kinstlinger; James Basilion
Journal:  Bioconjug Chem       Date:  2015-03-30       Impact factor: 4.774

6.  Mechanisms of ZnII-activated magnetic resonance imaging agents.

Authors:  Jody L Major; Rene M Boiteau; Thomas J Meade
Journal:  Inorg Chem       Date:  2008-10-18       Impact factor: 5.165

7.  Structural optimization of Zn(II)-activated magnetic resonance imaging probes.

Authors:  Lauren M Matosziuk; Jonathan H Leibowitz; Marie C Heffern; Keith W MacRenaris; Mark A Ratner; Thomas J Meade
Journal:  Inorg Chem       Date:  2013-06-18       Impact factor: 5.165

8.  Bioresponsive, cell-penetrating, and multimeric MR contrast agents.

Authors:  Jody L Major; Thomas J Meade
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

9.  Self-Immolative Activation of β-Galactosidase-Responsive Probes for In Vivo MR Imaging in Mouse Models.

Authors:  Laura M Lilley; Sarah Kamper; Michael Caldwell; Zer Keen Chia; David Ballweg; Luke Vistain; Jeffrey Krimmel; Teresa Anne Mills; Keith MacRenaris; Paul Lee; Emily Alexandria Waters; Thomas J Meade
Journal:  Angew Chem Int Ed Engl       Date:  2019-11-21       Impact factor: 15.336

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.